Taking stock of the drug industry, from the lab to the medicine chestOctober 4, 2024Check out STAT+Sponsored By By Ed SilvermanPharmalot Columnist, Senior Writer Scott Olson/Getty Images Trump backs off proposal to slash prescription drug prices by linking them to foreign countries Trump is backing away from one of his biggest ideas to tackle the high cost of prescription drugs. By Rachel Cohrs Zhang STAT+ | Higher insurance costs eat into savings from drug pricing law by more than expected Higher insurance costs means the savings from the Inflation Reduction Act will be up to $20 billion less than expected, the CBO said. By John Wilkerson STAT+ | Medicare Advantage market expected to grow in 2025, despite big changes from insurers Insurers have made important tweaks to 2025 plans that will force millions of members to shell out more for their prescription drugs and care. By Tara Bannow and Bob Herman Adobe STAT+ | Q&A: AI is coming for lots of jobs. What about that of the cancer researcher? Whether Sam Altman is right in suggesting AI will replace the PI comes down to the nature of creative thinking, says a Broad biologist. By Angus Chen STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Pharmalot? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2024, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments